PG

Procter & Gamble Company
D

PG

Arincen73/100B
165.390
USD
-1.71
(-1.02%)
Post Trading·165.400USD+0.010(+0.01%)
Last updated: · Delayed 15 min
Fair value167.60Plus-1%133Price 165.39204
Q2 FY2027 · Earnings report
EPS estimate 1.81Revenue estimate 22.85B
OverviewFinancialsNewsForecastEarningsDividendsCompany

Procter & Gamble Company net income 1986–2027

Procter & Gamble Company earned 4.73B USD in Q1 FY2027, the three months to 30 September 2026, down 0.4% on the same quarter a year before. Procter & Gamble Company's net income over the last twelve months was 16.03B USD, down 4.4% on the twelve months before. In fiscal year 2026 it earned 16.05B USD, up 0.5% on the year before.

Last updated 5 Nov 2026 · Next report 21 Jan 2027

Net income

Net income · +4.3% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 202616.03B-4.40%18.23%87.92B
FY202630 Jun 202616.05B+0.45%18.44%87.03B
FY202530 Jun 202515.97B+7.36%18.95%84.28B
FY202430 Jun 202414.88B+1.54%17.70%84.04B
FY202330 Jun 202314.65B-0.60%17.87%82.01B
FY202230 Jun 202214.74B+3.05%18.38%80.19B
FY202130 Jun 202114.31B+9.82%18.79%76.12B
FY202030 Jun 202013.03B+234.28%18.36%70.95B
FY201930 Jun 20193.90B-60.03%5.76%67.68B
FY201830 Jun 20189.75B-36.38%14.59%66.83B
FY201730 Jun 201715.33B+45.85%23.56%65.06B
FY201630 Jun 201610.51B+49.35%16.09%65.30B
FY201530 Jun 20157.04B-39.57%9.95%70.75B
FY201430 Jun 201411.64B+2.93%15.65%74.40B
FY201330 Jun 201311.31B+5.17%14.12%80.12B
FY201230 Jun 201210.76B-8.82%13.12%82.01B
FY201130 Jun 201111.80B-7.37%14.55%81.10B
FY201030 Jun 201012.74B+11.47%16.42%77.57B
FY200930 Jun 200911.43B-5.38%14.90%76.69B
FY200830 Jun 200812.08B+16.78%14.77%81.75B
FY200730 Jun 200710.34B+19.07%13.52%76.48B
FY200630 Jun 20068.68B+25.44%12.73%68.22B
FY200530 Jun 20056.92B+12.46%12.20%56.74B
FY200430 Jun 20046.16B+18.70%11.98%51.41B
FY200330 Jun 20035.19B+19.16%11.96%43.38B
FY200230 Jun 20024.35B+48.94%10.82%40.24B
FY200130 Jun 20012.92B-17.50%7.45%39.24B
FY200030 Jun 20003.54B-5.87%8.87%39.95B
FY199930 Jun 19993.76B-0.45%9.87%38.13B
FY199830 Jun 19983.78B+10.69%10.17%37.15B
FY199730 Jun 19973.42B+12.11%9.55%35.76B
FY199630 Jun 19963.05B+15.16%8.63%35.28B
FY199530 Jun 19952.65B+19.63%7.90%33.48B
FY199430 Jun 19942.21B—7.30%30.30B
FY199330 Jun 1993-656.00M-135.04%-2.16%30.43B
FY199230 Jun 19921.87B+5.58%6.38%29.36B
FY199130 Jun 19911.77B+10.67%6.56%27.03B
FY199030 Jun 19901.60B+32.84%6.65%24.08B
FY198930 Jun 19891.21B+18.24%5.64%21.40B
FY198830 Jun 19881.02B+211.93%5.28%19.34B
FY198730 Jun 1987327.00M-53.88%1.92%17.00B
FY198630 Jun 1986709.00M—4.59%15.44B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Procter & Gamble Company's profit

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.